Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade.

Molecular Cancer
Chi YanAnn Richmond

Abstract

While immune checkpoint blockade (ICB) is the current first-line treatment for metastatic melanoma, it is effective for ~ 52% of patients and has dangerous side effects. The objective here was to identify the feasibility and mechanism of RAS/RAF/PI3K pathway inhibition in melanoma to sensitize tumors to ICB therapy. Rigosertib (RGS) is a non-ATP-competitive small molecule RAS mimetic. RGS monotherapy or in combination therapy with ICB were investigated using immunocompetent mouse models of BRAFwt and BRAFmut melanoma and analyzed in reference to patient data. RGS treatment (300 mg/kg) was well tolerated in mice and resulted in ~ 50% inhibition of tumor growth as monotherapy and ~ 70% inhibition in combination with αPD1 + αCTLA4. RGS-induced tumor growth inhibition depends on CD40 upregulation in melanoma cells followed by immunogenic cell death, leading to enriched dendritic cells and activated T cells in the tumor microenvironment. The RGS-initiated tumor suppression was partially reversed by either knockdown of CD40 expression in melanoma cells or depletion of CD8+ cytotoxic T cells. Treatment with either dabrafenib and trametinib or with RGS, increased CD40+SOX10+ melanoma cells in the tumors of melanoma patients and patient...Continue Reading

References

Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·L Bugeon, M J Dallman
Dec 19, 2002·Cancer Gene Therapy·Alex W Tong, Marvin J Stone
Dec 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Seran C HillAristides G Eliopoulos
Jan 24, 2006·Cell Death and Differentiation·N T GeorgopoulosL K Trejdosiewicz
Jul 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuru MengThomas F Gajewski
Apr 23, 2008·Current Protocols in Human Genetics·S A ForbesM R Stratton
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio JimenoRoss C Donehower
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Feb 2, 2011·The Journal of Cell Biology·Pauline G KnoxAristides G Eliopoulos
Feb 22, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Colby M ChapmanAdrian Wiestner
Aug 29, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Wolchok
Sep 30, 2014·The New England Journal of Medicine·James LarkinAntoni Ribas
Nov 18, 2014·Frontiers in Immunology·Adam F CunninghamIan R Henderson
Dec 3, 2014·Annales de dermatologie et de vénéréologie·J CharlesB Busser
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders
Jan 23, 2015·Nature Communications·Adnan R KhanPadraic G Fallon
Jul 4, 2015·Journal of Translational Medicine·Jenny E Hernandez-DaviesMei Kong
Jul 21, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ammad Ahmad FarooqiHsueh-Wei Chang
Feb 5, 2016·European Journal of Immunology·Jason WaithmanSammy Bedoui
Apr 9, 2016·Journal of Basic and Clinical Pharmacy·Anroop B Nair, Shery Jacob
Apr 23, 2016·Cell·Sai Krishna Athuluri-DivakarE Premkumar Reddy
May 7, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Yi-Han DaiKung-Chao Chang
Jul 19, 2016·Annals of Translational Medicine·José Luís ManzanoAnna Martínez-Cardús
Dec 9, 2016·Expert Review of Anticancer Therapy·Gregory L BeattyKristen B Long
Mar 25, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Wolfram C M DempkeStephen P Dale
Apr 1, 2017·Cell Death and Differentiation·Caitlin E Fogarty, Andreas Bergmann
May 26, 2017·Cancer·Bobby Y ReddyHensin Tsao
Jul 10, 2017·Seminars in Cell & Developmental Biology·Neha Diwanji, Andreas Bergmann
Sep 12, 2017·The New England Journal of Medicine·Georgina V LongJohn M Kirkwood

❮ Previous
Next ❯

Software Mentioned

Leica
Fiji
FlowJo
cBioPortal
GraphPad
Prism
R
DESeq2
ImageJ

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.